BAYLOR COLLEGE OF MEDICINE, CHI St. Luke’s Health and the Texas Heart Institute have expanded their educational, clinical and research affiliations in conjunction with Catholic Health Initiatives, which sponsors and operates the newly named CHI St. Luke’s Health.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
